Oliver Wyman is proud to be participating at Longwood Healthcare Leaders Forum on January 6-7, 2022. Join Oliver Wyman Healthcare and Life Sciences partner John Westwood as he moderates a panel discussion on accelerating drug development alongside panelists from Lyell Immunopharma, Affinia Therapeutics, Alto Neuroscience and Axcella Therapeutics
Access to the forum is by invitation only.
Longwood Healthcare Leaders meetings are invitation-only forums typically held at leading academic institutions. Biopharma CEOs, heads of R&D, academic researchers, and healthcare investors join off-the-record discussions that generate new company ideas and approaches for Longwood Fund and members of the biopharma ecosystem, creating strategic business opportunities to advance the industry and bring important medicines to patients in need.
THURSDAY, JANUARY 6, 2022
2:40 pm PT / 5:40 pm ET | ACCELERATING DRUG DEVELOPMENT
Tina Albertson, CMO, Lyell Immunopharma; Charlie Albright, CSO, Affinia Therapeutics; Amit Etkin, CEO, Alto Neuroscience; Bill Hinshaw, CEO, Axcella Therapeutics
Moderator: John Westwood, Partner & Global Life Sciences Business Leader, Oliver Wyman